Keros Therapeutics Inc (KROS)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $196.83M
Last updated: Nov 17, 2026 at 4:34 PM ET
Keros Therapeutics Inc (KROS) Stock Chart
Keros Therapeutics (KROS) has a latest price of $11.31 on Nov 17, 2026, 49.8% below its 52-week high of $22.55. Its price fell 34.5% over the past 12 months. The month-end price fell 73.5% over the 5 years through Oct 2026, a compound annual decline of 23.3%.
Price Chart
From Apr 2020 to Oct 2026, its highest month-end close was $75.61 in Nov 2020 and its lowest $10.07 in Jul 2026, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart KROS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for KROS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price rose 1.9%, and over 6 months it rose 14.1%. The month-end price fell 61.3% over the 3 years through Oct 2026, a compound annual decline of 27.1%.
| Period | Change |
|---|---|
| 1 month | +2.3% |
| 3 months | +1.9% |
| 6 months | +14.1% |
| 12 months | -34.5% |
| 12 months, with dividends | -34.5% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -61.3% | -27.1% |
| 5 years | -73.5% | -23.3% |
Price by Year
Its best calendar year was 2025, when the price rose 28.6%, and its weakest was 2024, when it fell 60.2%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $11.04 | -45.8% |
| 2025 | $20.36 | +28.6% |
| 2024 | $15.83 | -60.2% |
| 2023 | $39.76 | -17.2% |
| 2022 | $48.02 | -17.9% |
| 2021 | $58.51 | -17.1% |
Trading Range
The price is 2.7% above its 50-day average of $11.01 and 2.1% below its 200-day average of $11.55.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $11.31 | |
| 52-week high | $22.55 | -49.8% |
| 52-week low | $8.98 | +25.9% |
| 50-day average | $11.01 | +2.7% |
| 200-day average | $11.55 | -2.1% |
Price Risk
Over 3 years, its largest fall from a peak was 87.0%.
| Measure | Value |
|---|---|
| 1-year beta | 1.19 |
| Largest fall, 1 year | -58.0% |
| Largest fall, 3 years | -87.0% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About KROS
What is KROS's 1-year price change?
Keros Therapeutics's price fell 34.5% over the past 12 months. With dividends included, the 12-month total return was -34.5%.
What is KROS's 5-year price change?
Keros Therapeutics's month-end price fell 73.5% over the 5 years through Oct 2026, a compound annual decline of 23.3%. These figures leave out dividends.
What is KROS's 52-week high and low?
Keros Therapeutics's 52-week high is $22.55 and its 52-week low is $8.98. Its latest price of $11.31 on Nov 17, 2026 is 49.8% below the high.
What is KROS's beta?
Keros Therapeutics's 1-year beta against the S&P 500 is 1.19, so its price has moved about in line with the market over the past year. Its largest fall from a peak over the past year was 58.0%.
Is the KROS chart free?
Yes. Advanced Charting for KROS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
KROS pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors